Table 2 Comparisons between different OSA groups

N (%)

286 (29.5)

318 (32.7)

367 (37.8)

Age (years)

56.5 ± 13.3

59.9 ± 11.4

58.8 ± 11.9

0.002

Male (%)

71.7

73.6

82.6

<0.001

BMI (Kg/m²)

24.6 ± 3.6

24.8 ± 3.4

26.6 ± 4.4

<0.001

SBP (mm Hg)

137.3 ± 20.4

137.7 ± 21.5

137.1 ± 21.5

0.934

DBP (mm Hg)

79.3 ± 13.6

79.3 ± 14.8

79.4 ± 14.0

0.985

AHI

1.7 ± 1.4

9.2 ± 2.7

33.1 ± 15.7

<0.001

IVS (mm)

10.7 ± 1.8

11.2 ± 2.6

11.5 ± 2.1

<0.001

LVPW (mm)

10.2 ± 1.8

10.3 ± 1.7

10.7 ± 1.9

0.001

HbA1c (%)

6.1 ± 1.1

6.2 ± 1.1

6.2 ± 1.2

0.838

Creatinine (μmol/L)

91.6 ± 48.0

92.7 ± 45.3

104.5 ± 79.2

0.012

BUN (mmol/L)

5.5 ± 3.2

5.7 ± 2.9

5.9 ± 2.8

0.290

FPG (mmol/L)

6.2 ± 2.6

6.3 ± 2.5

6.6 ± 3.4

0.097

Triglyceride (mmol/L)

1.9 ± 0.3

1.7 ± 0.1

1.9 ± 0.1

0.665

Total cholesterol (mmol/L)

4.5 ± 1.3

4.5 ± 1.3

4.6 ± 1.2

0.442

LDL-C (mmol/L)

2.7 ± 1.0

2.7 ± 1.0

2.7 ± 1.0

0.938

HDL-C (mmol/L)

1.0 ± 0.3

1.0 ± 0.2

1.0 ± 0.2

0.892

Proteinuria (%)

17.1

18.5

22.0

0.027

Diabetes mellitus (%)

19.6

23.0

25.6

0.038

Dyslipidemia (%)

10.5

14.2

15.0

0.057

Aortic dissection (%)

20.3

20.8

19.1

0.358

Aneurysm (%)

4.5

4.7

6.0

0.221

CHD (%)

37.4

39.9

43.6

0.058

Cerebrovascular disease (%)

6.6

11.0

9.0

0.195

Heart failure (%)

19.2

17.6

25.6

0.019

Atrial fibrillation (%)

8.4

10.1

8.2

0.462

HCM (%)

1.7

3.1

3.5

0.112

Anti-platelet (%)

49.0

53.1

55.3

0.060

Statins (%)

59.1

68.2

65.7

0.057

ACEI (%)

22.0

22.0

22.1

0.514

ARB (%)

49.7

45.3

46.6

0.249

Beta-blocker (%)

59.4

62.9

69.5

0.004

Alpha-blocker (%)

6.6

6.3

6.5

0.514

CCB (%)

55.2

58.5

55.9

0.478

Diuretic (%)

16.1

16.7

20.4

0.076

Warfarin (%)

2.0

2.5

2.6

0.512